CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Clinical trial NCT06110598 · WITHDRAWN

Trial details

NCT number: NCT06110598
Sponsor: Case Comprehensive Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer Pancreas Adenocarcinoma

Start date: 2024-12-01
Primary completion: 2026-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.